NCT01202214View on ClinicalTrials.gov

Repeat Dose Safety Study for Compound to Treat Asthma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2010

Conditions
Asthma
Interventions
DRUG

1440115

DRUG

Placebo

matching placebo

Trial Locations (1)

3004

Investigational Site, Melbourne

Sponsors

Lead Sponsor

Accenture
All Listed Sponsors
lead

Accenture

INDUSTRY

NCT01202214 - Repeat Dose Safety Study for Compound to Treat Asthma | Biotech Hunter | Biotech Hunter